NKX101

· Nkarta, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NKX101, covering 2024-12-27 to 2024-12-27. Get the full timeline:

Most recent: Clinical Trial Update: NKX101, Intravenous Allogeneic CAR NK Cells, in Adults With AML or MDS [Phase 1]